Radius Raises $57.5 Million

Radius, a Cambridge, Mass.-based drug company focused on osteoporosis and women's health, has raised $57.5 million in second-round funding. The Wellcome Trust and existing investor MPM Capital co-led the deal. Other new backers included BB Biotech Ventures and Scottish Widows Investment Partnership, while other returnees included HealthCare Ventures and Oxford Bioscience Partners. The company previously had raised $24 million. www.radiuspharm.com